Dose Estimation Using 3D Transformer Models in High-Dose-Rate Brachytherapy for Cervical Cancer - Top-Institutions - MDSpire

Dose Estimation Using 3D Transformer Models in High-Dose-Rate Brachytherapy for Cervical Cancer

  • By

  • Weiwei Guo

  • Wanwei Jian

  • Lin Zhu

  • Bailin Zhang

  • Qiang He

  • Geng Yang

  • Xuetao Wang

  • January 20, 2026

  • 0 min

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Radiation Oncology
    • Medical Physics
    • Cancer Research

  • #2

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Radiation Oncology
    • Medical Physics
    • Oncology Research

  • #3

    Dana-Farber/Brigham and Women’s Cancer Center
    Dana-Farber/Brigham and Women’s Cancer Center

    Boston, MA

    Key Differentiators

    • Radiation Oncology
    • Medical Physics
    • Cancer Informatics

  • #4

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Radiation Oncology
    • Medical Physics
    • Biomedical Engineering

  • #5

    Stanford University School of Medicine
    Stanford University School of Medicine

    Stanford, CA

    Key Differentiators

    • Radiation Oncology
    • Medical Physics
    • Artificial Intelligence in Medicine

Original Source(s)

Dose Estimation Using 3D Transformer Models in High-Dose-Rate Brachytherapy for Cervical Cancer

  • by Weiwei Guo, Wanwei Jian, Lin Zhu, Bailin Zhang, Qiang He, Geng Yang, Xuetao Wang

  • January 20, 2026

Related Content

Medical Oddities: Something Viral is Lurking in the Dust

Everyday things like yawns, tea, dust, and kimchi suddenly look medically important.

Case Report: Ovarian dysgerminoma mimicking a sex cord-stromal tumor with hyperandrogenism: diagnostic challenges and molecular insights

Validation of a cervical CDO1/CELF4 methylation test for endometrial cancer: a prospective paired-sample comparison with intrauterine specimen